J. Loveless

机构：Saint Luke's Health System

发表论文 8 篇 · 总被引 1837 次 · h-index 4

代表论文

• Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks (2006 · Arthritis & Rheumatism · 被引 1650)
• Improvement in patient‐reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy (2008 · Arthritis Care & Research · 被引 106)
• Multiple Courses of Rituximab Produce Sustained Clinical and Radiographic Efficacy and Safety in Patients with Rheumatoid Arthritis and an Inadequate Response to 1 or More Tumor Necrosis Factor Inhibitors: 5-Year Data from the REFLEX Study (2012 · The Journal of Rheumatology · 被引 70)
• Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study) (2006 · Digital Access to Libraries · 被引 5)
• Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial (2026 · Annals of the Rheumatic Diseases · 被引 4)
• POS0620 IMMUNOGENICITY OF THE RECOMBINANT ZOSTER VACCINE IN PEOPLE WITH RHEUMATOID ARTHRITIS USING ABATACEPT (2024 · Annals of the Rheumatic Diseases · 被引 2)